So from this what do you presume is the effect of 6 to 12 mgs of cabergoline over a period of 4 months?![]()
Cabergoline-induced tricuspid regurgitation: Case report and review of literature
The increased risk of cardiac valve disease in patients treated for Parkinson's disease with cabergoline has raised concerns about the safety of treatment with ergot-derived dopamine agonists in patients with endocrine diseases, especially prolactinoma. ...www.ncbi.nlm.nih.gov
![]()
Valvular heart disease and the use of dopamine agonists for Parkinson's disease - PubMed
The frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non-ergot-derived dopamine agonists, as compared with control subjects. These findings should be considered in evaluating the risk-benefit...pubmed.ncbi.nlm.nih.gov
![]()
Dopamine agonists and the risk of cardiac-valve regurgitation - PubMed
In this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.pubmed.ncbi.nlm.nih.gov